Phase I/II study of vinorelbine and exisulind as first-line treatment of advanced non-small cell lung cancer in patients at least 70 years old: a Wisconsin Oncology Network Study

INTRODUCTION: Exisulind is an apoptotic agent with preclinical activity in non-small cell lung cancer (NSCLC). Vinorelbine is safe and effective in older patients with advanced NSCLC. We assessed these agents together as palliative treatment for older patients with advanced NSCLC. METHODS: Chemother...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Attia, Steven, Traynor, Anne M., Kim, KyungMann, Merchant, Joseph J., Hoang, Tien, Ahuja, Harish G., Beatty, Peter A., Hansen, Richard M., Masters, Gregory A., Oettel, Kurt R., Shapiro, Gary R., Larson, Martha M., Larson, Marilyn L., Schiller, Joan H.
Format: Artigo
Idioma:Inglês
Publicat: 2008
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2562273/
https://ncbi.nlm.nih.gov/pubmed/18758305
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e3181834fa1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars